Cardiol Pb Ratio from 2010 to 2024
| CRDL Stock | CAD 2.26 0.05 2.16% |
PB Ratio | First Reported 2010-12-31 | Previous Quarter 2.51037411 | Current Value 2.38 | Quarterly Volatility 15.35172843 |
Check Cardiol Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardiol Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 2.3 M, Interest Income of 2.9 M or Depreciation And Amortization of 190.7 K, as well as many indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0 or PTB Ratio of 2.38. Cardiol financial statements analysis is a perfect complement when working with Cardiol Therapeutics Valuation or Volatility modules.
Cardiol | Pb Ratio |
Pair Trading with Cardiol Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cardiol Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Cardiol Stock
The ability to find closely correlated positions to Cardiol Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cardiol Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cardiol Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cardiol Therapeutics Class to buy it.
The correlation of Cardiol Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cardiol Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cardiol Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cardiol Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Cardiol Therapeutics Correlation against competitors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.